The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

TRANSIENT BRAIN SYNDROME AS A NON-FATAL REACTION TO COMBINED PARGYLINE IMIPRAMINE TREATMENT

Published Online:https://doi.org/10.1176/ajp.121.4.397

A case of toxic reaction to combined pargyline—imipramine treatment is described, consisting of a mild acute brain syndrome and cardio-vascular irritability. Discussion of the possible toxic mechanism is given. The need for careful drug history is pointed out.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.